These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16610783)

  • 1. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
    Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
    J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
    Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
    Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies on vitamin D lactam derivatives as vitamin D receptor antagonist.
    Cho K; Uneuchi F; Kato-Nakamura Y; Namekawa J; Ishizuka S; Takenouchi K; Nagasawa K
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4287-90. PubMed ID: 18635349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha,25-Dihydroxyvitamin D(3)-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells.
    Ishizuka S; Kurihara N; Hiruma Y; Miura D; Namekawa J; Tamura A; Kato-Nakamura Y; Nakano Y; Takenouchi K; Hashimoto Y; Nagasawa K; Roodman GD
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):269-77. PubMed ID: 18501591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel vitamin D3 analogs, 1alpha, 25(OH)2D(3)-26, 23-lactam (DLAMs), antagonize bone resorption via suppressing RANKL expression in osteoblasts.
    Inada M; Tsukamoto K; Hirata M; Takita M; Nagasawa K; Miyaura C
    Biochem Biophys Res Commun; 2008 Aug; 372(3):434-9. PubMed ID: 18489902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
    Yamamoto K; Inaba Y; Yoshimoto N; Choi M; DeLuca HF; Yamada S
    J Med Chem; 2007 Mar; 50(5):932-9. PubMed ID: 17298045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues.
    Sicinski RR; Prahl JM; Smith CM; DeLuca HF
    J Med Chem; 1998 Nov; 41(23):4662-74. PubMed ID: 9804706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
    Saito N; Matsunaga T; Saito H; Anzai M; Takenouchi K; Miura D; Namekawa J; Ishizuka S; Kittaka A
    J Med Chem; 2006 Nov; 49(24):7063-75. PubMed ID: 17125259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
    Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
    Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
    Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
    Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic studies of (23S,25R)-1α,25-dihydroxyvitamin D
    Akagi Y; Nagata A; Odagi M; Nagasawa K
    J Steroid Biochem Mol Biol; 2018 Mar; 177():240-246. PubMed ID: 28757443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methylene analogs of 1alpha-hydroxy-19-norvitamin D3: synthesis, biological activities and docking to the ligand binding domain of the rat vitamin D receptor.
    Grzywacz P; Plum LA; Sicinska W; Sicinski RR; Prahl JM; DeLuca HF
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):13-7. PubMed ID: 15225739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis.
    Glebocka A; Sicinski RR; DeLuca HF
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation.
    Fujishima T; Kittaka A; Kurihara M; Saito N; Honzawa S; Kishimoto S; Sugiura T; Waku K; Takayama H
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):89-92. PubMed ID: 15225752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of new 1alpha,25-dihydroxy-19-norvitamin D3 analogs with modifications in both the A-ring and the side chain.
    Shimizu M; Miyamoto Y; Kobayashi E; Shimazaki M; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem; 2006 Jun; 14(12):4277-94. PubMed ID: 16503143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of TEI-9647 derivatives as Vitamin D3 antagonists.
    Takenouchi K; Sogawa R; Manabe K; Saitoh H; Gao Q; Miura D; Ishizuka S
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):31-4. PubMed ID: 15225742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
    Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.
    Posner GH; Lee SH; Kim HJ; Peleg S; Dolan P; Kensler TW
    Bioorg Med Chem; 2005 Apr; 13(8):2959-66. PubMed ID: 15781405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity.
    Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives.
    Glebocka A; Sicinski RR; Plum LA; Clagett-Dame M; DeLuca HF
    J Med Chem; 2006 May; 49(10):2909-20. PubMed ID: 16686534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.